SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Serum from vaccinated persons was assayed for ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two doses of the BNT162b2, mRNA-1273, or ChAdOx1-S vaccine had serum that poorly neutralized omicron, but those who had recovered from infection and were then vaccinated or who had been vaccinated and had breakthrough infe...
Alternative Titles
Full title
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8781314
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8781314
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2119236
